<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231013059702N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-02-11</date_registration>
      <primary_sponsor>Oroumia University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effect of Virtual Reality in intrauterine sperm insemination</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of Virtual Reality on perceived hospital anxiety, worry and depression and the rate of pregnancy in women who are candidates for intrauterine sperm insemination</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-01-11</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>114</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/75096</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: The randomization method will be of a limited type called random allocation law; First, 114 cards (numbered from 1 to 114) will be prepared for the total number of people under study; Group membership will be determined based on the removal of cards; It should be noted that these cards will be placed inside white envelopes without name and mark and the cards will be chosen by the participants in the presence of a person other than the researcher; The participant and the researcher will be unaware of the content inside the envelope ; Even numbers will be assigned in the intervention group and odd numbers in the control group ; Then the removed card will be discarded, Blinding description: The cards identifying the groups of participants will be inside anonymous white envelopes and these cards will be chosen by the participants in the presence of a person other than the researcher ; The participant and the  
                  . researcher will be unaware of the content inside the envelope.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Adjustment disorders (occurrence of worry, anxiety and depression following a special and critical situation in life). Condition 2: Reaction to extreme stress, unspecified (commonly seen in infertility). Condition 3: Dangerously obsessive thoughts or ruminations (which prevents the infertile person from going to the hospital to receive further treatment and can lead to more dangerous results for the person).</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: People in the intervention group will complete the Pennsylvania anxiety and hospital anxiety and depression questionnaires by Sigmund and Snaith one hour before the sperm transfer process into the uterus and half an hour after the sperm transfer process. It should also be noted that these people will use virtual reality glasses that contain sounds and images of nature with soothing content for twenty minutes before the start of the sperm transfer process and for ten minutes during the sperm transfer process. Intervention 2: Control group:  People in the control group will complete the Pennsylvania anxiety and hospital anxiety and depression questionnaires by Sigmund and Snaith one hour before the start of the sperm transfer process into the uterus and half an hour after the sperm transfer process. It should be noted that the people of the control group will only benefit from the conditions, training and standard care of the respective center.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data from hospital worry, anxiety and depression questionnaires and demographic questionnaire will be shared.

When:
Access to documents and data files starts six months after the publication of the article and results.

To whom:
The obtained data will be accessible to researchers working in academic and scientific institutions, as well as people working in the relevant industry, from the time of access to them.

Conditions:
The data will be provided to the mentioned people for further guidance in conducting similar studies (for example, the use of an intervention similar to virtual reality in the field of infertility or the use of virtual reality glasses in other fields other than infertility).

Where to obtain:
Dear applicants, they can send more information to the email address: ghazalehgholamii76@gmail.com 
or postal address: Bostan Girls Student Dormitory, Zakir Street ,Apadana Crossroads, Shahid Bahonar Highway, Urmia by zip code:6257757168
or contact number :  0098 09909358804  (respondent: Ghazaleh Gholami)
 refer.

How to obtain:
Applicants for documents can contact the respondent through one of the mentioned communication channels, And after stating their reasons for requesting documents, The necessary information will be provided to them within a maximum period of one week.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ghazaleh Gholami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Midwifery group, School of Nursing and Midwifery, Urmia University of Medical Sciences,  Kilometer 11 Sero Road, Urmia</address>
        <city>Urmia</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5714783734</zip>
        <telephone>+98 44 4553 4222</telephone>
        <email>ghazalehgholamii76@gmail.com</email>
        <affiliation>Oroumia University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ghazaleh Gholami</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Midwifery group, School of Nursing and Midwifery, Urmia University of Medical Sciences,  Kilometer 11 Sero Road, Urmia</address>
        <city>Urmia</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5714783734</zip>
        <telephone>+98 44 4553 4222</telephone>
        <email>ghazalehgholamii76@gmail.com</email>
        <affiliation>Oroumia University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Consent to participate in the study
Not having children at home
The first treatment experience with sperm intrauterine insemination
Infertility of female origin
No physical illness
Not having mental disorders and no history of drug use in the mental and psychological field
No visual impairments
No hearing disorders
No movement disorders
No addiction to smoking, drugs and alcohol
The absence of stressful events in the last 6 months, such as the death of loved ones, accidents, etc</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Infertility of male origin
A candidate for treating infertility with methods other than intrauterine sperm insemination</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F43.2</hc_code>
      <hc_code>F43.9</hc_code>
      <hc_code>F42.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Adjustment disorders</hc_keyword>
      <hc_keyword>Reaction to severe stress, unspecified</hc_keyword>
      <hc_keyword>Predominantly obsessional thoughts or ruminations</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: People in the intervention group will complete the Pennsylvania anxiety and hospital anxiety and depression questionnaires by Sigmund and Snaith one hour before the sperm transfer process into the uterus and half an hour after the sperm transfer process. It should also be noted that these people will use virtual reality glasses that contain sounds and images of nature with soothing content for twenty minutes before the start of the sperm transfer process and for ten minutes during the sperm transfer process.</i_keyword>
      <i_keyword>Control group:  People in the control group will complete the Pennsylvania anxiety and hospital anxiety and depression questionnaires by Sigmund and Snaith one hour before the start of the sperm transfer process into the uterus and half an hour after the sperm transfer process. It should be noted that the people of the control group will only benefit from the conditions, training and standard care of the respective center.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Worry score in the Pennsylvania Worry Questionnaire. Timepoint: Measuring people's level of concern using a questionnaire one hour before the start of the sperm transfer process into the uterus and half an hour after the sperm transfer process into the uterus. Method of measurement: Pennsylvania Anxiety Inventory.</prim_outcome>
      <prim_outcome>Hospital anxiety and depression score in Zigmond and Snaith hospital anxiety and depression questionnaire. Timepoint: Measuring the level of anxiety and depression of people using a questionnaire one hour before the start of the sperm transfer process into the uterus and half an hour after the sperm transfer process into the uterus. Method of measurement: Zigmond and Snaith Hospital Anxiety and Depression Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The percentage of people who have a positive or negative pregnancy test result. Timepoint: 14 days after the sperm transfer process into the uterus. Method of measurement: Beta pregnancy blood test.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Oroumia University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-01-10</approval_date>
        <contact_name>Ethics Committee of Urmia University of Medical Sciences</contact_name>
        <contact_address>Midwifery group, School of Nursing and Midwifery, Urmia University of Medical Sciences,  Kilometer 11 Sero Road, Urmia Urmia West Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
